Today, genomics and genetic testing are standard terms people encounter when they research cancer treatment. As researchers continue studying genetics and cancer development, new findings emerge yearly. Combined with a precision medicine or personalized treatment approach, genomic information can make…

Although multiple myeloma is considered a relatively rare cancer, it is the second most common type of blood cancer, after leukemia. The exact cause is unknown, but certain factors such as genetic mutations, exposure to radiation or certain chemicals, and…

Cancer treatment sometimes means finding clinical trials that will offer patients the potential to take an active role in their cancer treatments as well as provide hope for those facing difficult diagnoses. With clinical trial matching and trial support, participating…